Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonistsRobin D Clark, Nicholas C Ray, Paul Blaney, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazolesScott P Webster, Margaret Binnie, Kirsty M M McConnell, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Richard J Bull, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitorsM J Barnes, N Cooper, R J Davenport, et al.
Medical Physics|October 8, 2003
A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiographyJ L Humm, D Ballon, Y C Hu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonistsSue Cramp, Hazel J Dyke, Christopher Higgs, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activityRobin D Clark, Nicholas C Ray, Karen Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsGeorge M Buckley, Natasha Davies, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Ruth Braganza, et al.
Pageof 7